RadNet Inc. (RDNT)
RDNT trades on Nasdaq in Health Care, Medical Specialities. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$71.51
+0.03% on the day
Market cap
$5.6B
Mid cap
Revenue · 2025
$2.0B
+11.5% on 2024
Net income · 2025
-$18.6M
-0.9% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.
Profile
| Field | Value |
|---|---|
| Ticker | RDNT on Nasdaq |
| Sector | Health Care |
| Industry | Medical Specialities |
| Country | United States |
| IPO year | Not reported by the screener |
| SEC CIK | 0000790526 |
| SEC industry code | Services-Medical Laboratories |
| Incorporated in | DE |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $2.0B |
| Net income | -$18.6M |
| Operating income | $62.0M |
| Net margin | -0.9% |
| Operating margin | 3.0% |
| Revenue growth | +11.5% |
| Cash | $767.2M |
| Total assets | $3.8B |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 2.8× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document PROSPECTUS | 424B7 | 2026-08-14 |
| Latest annual report | 10-K | 2026-03-02 |
| Latest quarterly / interim | 10-Q | 2026-08-10 |
| Latest current report CURRENT REPORT | 8-K | 2026-08-14 |
| Latest proxy FORM DEFA 14A | DEFA14A | 2026-04-20 |
Source: SEC EDGAR submissions feed, 1,000 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | +1.3% |
| 1 month | -9.9% |
| 3 months | +10.4% |
| Year to date | -2.6% |
| 1 year | -3.1% |
| From 52-week high | -17.7% |
Source: Yahoo Finance daily closes, last bar 2026-10-14. Computed by Sophia Capital from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Medical Specialities
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| GRAL | GRAIL Inc. Common Stock | $140.35 | +2.17% | $6.3B |
| CON | Concentra Group Holdings Parent Inc. | $37.54 | 0.00% | $4.8B |
| BLLN | BillionToOne Inc. | $94.44 | +1.47% | $4.5B |
| CAI | Caris Life Sciences Inc. | $29.53 | -0.54% | $8.3B |
| VCYT | Veracyte Inc. | $43.11 | -2.07% | $3.5B |
| CDNA | CareDx Inc. | $65.43 | +3.66% | $3.4B |
| HSIC | Henry Schein Inc. | $85.03 | +0.95% | $9.5B |
| CELC | Celcuity Inc. | $63.19 | -4.04% | $3.1B |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier